Bill Gates is investing in Ginkgo Bioworks, a Boston-based start-up that prints synthetic DNA from a computer and is developing one of the world's largest libraries of usable designer genetic code.
Bayer has agreed to sell more of its crop science businesses to BASF as it seeks to wrap up its pending $62.5 billion acquisition of Monsanto, St.Louis Business Journal reports.
German drugmaker Bayer's adjusted core earnings slipped in the fourth quarter, as it tries to overcome weak demand for crop protection products in Brazil.